Effect of unintentional cyclophosphamide underdosing on diffuse large B-cell lymphoma response to chemotherapy: a retrospective review
M Al-Ahmadi, A Lazo-Langner, J Mangel… - … Open Access Journal, 2016 - cmajopen.ca
Background: Between March 2012 and March 2013, a miscommunication in labelling
between the drug compounder supplier and cancer centre pharmacies resulted in …
between the drug compounder supplier and cancer centre pharmacies resulted in …
[PDF][PDF] Effect of unintentional cyclophosphamide under-dosing on diffuse large b-cell lymphoma response–a retrospective review
M Al-Ahmadi, J Mangel, ADBS Phm, L Minuk - cmajopen.ca
Methods 4. Study design–appropriate 5. Setting–Appropriate. Could have been enhanced
by including some of the data of the entire patient population affected by this event, including …
by including some of the data of the entire patient population affected by this event, including …
Outcome and determinants of failure to complete primary R‐CHOP treatment for reasons other than non‐response among patients with diffuse large B‐cell lymphoma
T Wästerlid, S Harrysson… - American Journal of …, 2020 - Wiley Online Library
Patients with diffuse large B‐cell lymphoma (DLBCL) who fail to complete planned treatment
with R‐CHOP due to toxicity are sparsely described. We investigated the extent of failure to …
with R‐CHOP due to toxicity are sparsely described. We investigated the extent of failure to …
[HTML][HTML] Efficacy and Safety of Cyclophosphamide Low-Dose Pre-Phase Chemotherapy in Diffuse Large B Cell Lymphoma with Gastrointestinal Involvement
L Guarnera, F Meconi, R Secchi… - … of Hematology and …, 2022 - ncbi.nlm.nih.gov
Background Gastric Diffuse large B-cell lymphoma (DLBCL) is the most common extranodal
site of lymphoma's involvement (30%–40% of all extranodal lymphomas and 55%–65% of …
site of lymphoma's involvement (30%–40% of all extranodal lymphomas and 55%–65% of …
Association of occupational pesticide exposure with immunochemotherapy response and survival among patients with diffuse large B-cell lymphoma
S Lamure, C Carles, Q Aquereburu, P Quittet… - JAMA network …, 2019 - jamanetwork.com
Importance Professional use of pesticides is a risk factor for non-Hodgkin lymphoma. The
main biological mechanisms of pesticides and chemotherapy are genotoxicity and reactive …
main biological mechanisms of pesticides and chemotherapy are genotoxicity and reactive …
Neutrophil toxicity and primary prophylaxis in diffuse large B cell lymphoma treated with R-CHOP
N Naqi, J Khatak - Journal of Clinical Oncology, 2009 - ascopubs.org
e19548 Background: Three weekly R-CHOP therapy is regarded as standard treatment in
advanced stage Diffuse Large B Cell Lymphoma (DLBCL) patients with low to intermediate …
advanced stage Diffuse Large B Cell Lymphoma (DLBCL) patients with low to intermediate …
Dose Intensity and Reasons for Dose Alterations in Patients Excluded from Frontline Diffuse Large B-Cell Lymphoma Clinical Trials Based on Eligibility Criteria: A …
Background: Frontline clinical trials in DLBCL can exclude up to 24% of the real-world
population based on 5 lab-based eligibility criteria (Khurana et al. JCO 2021). Furthermore …
population based on 5 lab-based eligibility criteria (Khurana et al. JCO 2021). Furthermore …
[PDF][PDF] frequency and severity of neutropenia in diffuse large B-cell non hodgkin's lymphoma after first cycle of Chemotherapy comprising cyclophosphamide …
M Nadeem, M Idrees, J Khattak… - Journal of Ayub …, 2011 - demo.ayubmed.edu.pk
Background: Chemotherapy used for malignant diseases may produce severe neutropenia
in first cycle which may compel for dose modification and early termination of therapy. This …
in first cycle which may compel for dose modification and early termination of therapy. This …
[HTML][HTML] Pre-phase strategy to mitigate first cycle effect in diffuse large B cell lymphoma
AH Rudresha, SA Hassan, A Sreevalli… - Journal of the Egyptian …, 2022 - Springer
Context Treatment-related toxicities in DLBCL (diffuse large B cell lymphoma) patients are
higher in the initial phase of treatment (first cycle effect). Implementation of pre-phase …
higher in the initial phase of treatment (first cycle effect). Implementation of pre-phase …
Detection of the Incidence of Infections and Acute Biochemical Changes in Diffused Large B-Cell Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin …
Background: Acute biochemical changes, hepatotoxicity, nephrotoxicity and frequency of
infections are common in diffuse large B-cell Lymphoma patients undergoing …
infections are common in diffuse large B-cell Lymphoma patients undergoing …